Home | Log In | Register | Our Services | My Account | Contact | Help |
Shares Investor Evenings showcase up to four presentations from leading companies bringing them together in one room for one evening only.
Directors present their latest plans regarding development and growthAn opportunity to talk directly to the companies and personally put forward your questionsThe chance to network with other attendees over drinks and canapés - private investors, wealth managers, private client brokers, fund managers and financial institutionsThe evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Thursday 19th November 2015
Venue:Novotel Tower Bridge, London EC3N, 10 Pepys Street, London, EC3N 2NR
Event Timings:18.00 | Registration and coffee | |
18.30 | Presentations • David Reading, CEO & Director - Aureus Mining (AUE) • David Hornsby, CEO - Ideagen (IDEA) • Dr Jim Phillips, CEO - Midatech Pharma (MTPH) • Neil Ritson, Chairman - Solo Oil (SOLO) + More to be announced | |
20.30 | Drinks reception and canapés | |
21.30 | Close |
![]() | Aureus Mining Inc, through its subsidiaries, is engaged in the exploration and development of gold deposits in highly prospective and under-explored areas of Liberia and Cameroon. Aureus Mining’s activities are currently concentrated on the development of the New Liberty Gold Project in Liberia. The Company also owns 100% exclusive rights to the Weaju, Gondoja, Ndablama and Leopard Rock projects in Liberia and to the Batouri gold project in Cameroon. Our Vision is to be an African mid-tier gold producer with a brand recognised for sustainability, innovation and good relationships with the local communities. |
![]() | Ideagen Plc is a supplier of compliance based Information Management software with operations in the UK and the United States. We specialise in eGRC (Enterprise Governance, Risk and Compliance) and Healthcare solutions for organisations operating within highly regulated industries. As authors of an excellent portfolio of software products, Ideagen is able to provide complete content lifecycle solutions that enable organisations to meet their Regulatory and Quality Compliance standards, helping them to reduce costs and improve efficiency. Our Mission Statement is: “To enable our clients to improve their organisations by providing the tools which can help improve customer service, increase efficiency, reduce risk, enhance compliance, and lower costs". |
![]() | Midatech is a nanomedicine company focused on the development and commercialisation of multiple, high-value, targeted therapies for major diseases with unmet medical need. It is advancing a pipeline of novel clinical and pre-clinical product candidates based on its proprietary drug conjugate and sustained release delivery platforms with a clear focus on the key therapeutic areas of diabetes, cancer and neuroscience/ophthalmology. Midatech’s strategy is to develop its products in-house in rare cancers and with partners in other indications, and to accelerate growth of its business through strategic acquisition of complementary products and technologies. |
![]() | Introducing Solo Oil - Oil and gas Investment company- Listed on the London AiM Market (SOLO) Objectives To acquire and develop a diverse global portfolio of oil & gas assets Portfolio Non-operated oil & gas assets: - Major stake in the prolific Ruvuma Basin, Tanzania- Interest in Kiliwani North (KNDL), Tanzania- More than 5 tcf of prospective resources identified in Tanzania- Ntorya-1 (Tanzania) discovery flowed 20 mmscfd and 139 bopd- Participation in UK Weald Basin exploration projects, including Horse Hill- Strategic investment in Burj Africa, West Africa- Enhanced Oil Recovery project in Ontario, Canada |
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Wednesday 5th October 2016
Venue:Radisson Blu Hotel Edinburgh, 80 High Street, The Royal Mile, Edinburgh, EH11TH
Event Timings:18.00 | Registration and coffee | |
18.30 | Presentations • Mark Learmonth, CFO & Director - Caledonia Mining Corporation (CMCL) • Richard Gray, CEO - Scotgold Resources (SGZ) • Neil Ritson, Non-Executive Chairman - Solo Oil (SOLO) • James Parsons, CEO - Sound Energy (SOU) • Dr. George Morris, Chief Operations Officer - Valirx (VAL) | |
20.30 | Drinks reception and canapés | |
21.30 | Close |
![]() | Caledonia is an exploration, development and mining company focused on Southern Africa. Caledonia's primary asset is a 49% interest in the Blanket Mine in Zimbabwe which produced over 45,500 ounces of gold in 2013 at a cash cost of US$613/oz.Caledonia has a strong, experienced management team and Board of Directors with diverse expertise in gold production, exploration, mine development, finance and marketing. |
![]() | Australian Securities Exchange listed Scotgold Resources Limited (ASX:SGZ) was established in 2007 and listed on the ASX in January 2008. The company’s shares were admitted to trading on the AIM market of the London Stock Exchange (AIM:SGZ) in February 2010. The Company’s principal objective, since 2008, has been the advancement of the Cononish Gold and Silver Project in Scotland’s Grampian Highlands to a production decision and exploration of the highly prospective tenements comprising the Grampian Gold Project with the view of identifying further project opportunities. |
![]() | Introducing Solo Oil - Oil and gas Investment company- Listed on the London AiM Market (SOLO) Objectives To acquire and develop a diverse global portfolio of oil & gas assets Portfolio Non-operated oil & gas assets: - Major stake in the prolific Ruvuma Basin, Tanzania- Interest in Kiliwani North (KNDL), Tanzania- More than 5 tcf of prospective resources identified in Tanzania- Ntorya-1 (Tanzania) discovery flowed 20 mmscfd and 139 bopd- Participation in UK Weald Basin exploration projects, including Horse Hill- Strategic investment in Burj Africa, West Africa- Enhanced Oil Recovery project in Ontario, Canada |
![]() | Sound Energy is a well-funded Mediterranean upstream company, listed on AIM, with cost covering production, a cornerstone investor, a strategic partnership with Schlumberger (one of the largest companies in our sector) and an active and potentially transformational drill programme. |
![]() | Valirx Plc is an oncology-focussed Biopharmaceutical Company, developing treatments and diagnostics. Technologies are selected by using rigorous clinical and commercial processes to address unmet market needs. Clinical lead product is VAL201, a peptide for prostate cancer with follow-on indications in ovarian and breast cancers and endometriosis. Product VAL401, is a small molecule reformulation for lung cancers. The Company’s proprietary technology platform, GeneICE, enables selective silencing of rebellious genes’ inappropriate activity. VAL101, the first GeneICE therapeutic, targets and reduces expression of Bcl-2, implicated in about half of cancers. GeneICE extension to neurology and inflammatory diseases will follow. A novel diagnostic, the Nav3 system, detects pre-cancerous, cancerous and metastatic cells in tissue samples even before a tumour forms; indicating potential malignant formation. |